Shubh Medicorp (India) Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 19-12-2024
- Paid Up Capital ₹ 1.50 Cr
as on 19-12-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.15 Cr
as on 19-12-2024
- Revenue -8.03%
(FY 2023)
- Profit -17.37%
(FY 2023)
- Ebitda -23.25%
(FY 2023)
- Net Worth 15.16%
(FY 2023)
- Total Assets 15.60%
(FY 2023)
About Shubh Medicorp (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹10.15 Cr.
Hitesh Oswal, Amit Oswal, and Rajesh Oswal serve as directors at the Company.
- CIN/LLPIN
U74999PN2013PTC149470
- Company No.
149470
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shubh Medicorp (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hitesh Oswal  | Director | 19-Nov-2013 | Current |
| Amit Oswal | Director | 19-Nov-2013 | Current |
| Rajesh Oswal | Director | 19-Nov-2013 | Current |
Financial Performance of Shubh Medicorp (India).
Shubh Medicorp (India) Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.03% decrease. The company also saw a substantial fall in profitability, with a 17.37% decrease in profit. The company's net worth Soared by an impressive increase of 15.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shubh Medicorp (India)?
Unlock access to Shubh Medicorp (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹10.15 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 10.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2022 | Others | ₹1.25 Cr | Open |
| 27 May 2020 | Others | ₹1.90 Cr | Open |
| 24 Oct 2018 | Others | ₹7.00 Cr | Open |
How Many Employees Work at Shubh Medicorp (India)?
Unlock and access historical data on people associated with Shubh Medicorp (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shubh Medicorp (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shubh Medicorp (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.